atai Life Sciences NV (ATAI): מחיר למכירות

Atai Life Sciences N.V. (ATAI) maintains flexible supply chains that mitigate regulatory risks, as evidenced by the company's price/sales multiple on the GURU.Markets chart, where the value 603.50 represents the latest figure. The network of subsidiary structures accelerates the time-to-market for psychedelics, while insulation from macroeconomic volatility renders the business a defensive asset, ensuring stable demand for innovative drugs during recessionary periods.
פילוחים אנליטיים של חברת atai.life (ATAI)

This metric is calculated as the ratio of market capitalization to total sales, determining the value of each dollar of revenue in the eyes of investors. While low values may signal undervaluation or revenue degradation, for Atai Life Sciences N.V. (ATAI) and its high-margin innovative drugs, the company's price/sales multiple reflects the potential to scale scientific developments into monopoly profits.